Bu Yeap
University of Western Australia, WA, Australia
- This delegate is presenting an abstract at this event.
Bu Yeap (MBBS, FRACP, PhD) is a Professor in the Medical School, University of Western Australia, and consultant endocrinologist, Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Perth, Western Australia. He has longstanding interests testosterone and men’s health, the endocrinology of ageing, and the prevention and treatment of cardiometabolic disease. He leads the Androgens In Men Study, an international collaboration of cohort studies examining testosterone and health outcomes in men. He was a lead investigator in T4DM, an Australia-wide multicentre randomised controlled trial which showed that testosterone therapy on a background of lifestyle intervention prevented or reverted newly diagnosed type 2 diabetes mellitus in men at high risk. He jointly led with Prof Daniel Green the Tirzepatide and Resistance Exercise (T-REx) study, an investigator initiated randomised clinical trial of resistance exercise training added to tirzepatide treatment for obesity. Bu was President of the Endocrine Society of Australia in 2020-22. He has 330 publications including 260 original research articles, with >12,000 citations (Scopus).
Presentations this author is a contributor to:
Scaled Testosterone: A Novel Metric to Calibrate Serum Testosterone and SHBG in Men (#209)
5:30 PM
David J Handelsman
ESA Basic Science and Clinical Orals
Predicting circulating testosterone concentrations in individual men (#210)
5:45 PM
Bu B Yeap
ESA Basic Science and Clinical Orals
Effects of four years testosterone treatment on glycaemia, anthropometry, quality of life and safety: The T4DM RUN-ON sub-study. (#207)
5:00 PM
Gary Wittert
ESA Basic Science and Clinical Orals
Tirzepatide and Resistance Exercise training (T±REx) for obesity therapy: a randomised controlled trial. (#208)
5:15 PM
Bu B Yeap
ESA Basic Science and Clinical Orals